Controlling for DNA dosage with Whole Genome Sequencing improves ATAC-seq peak calling (opens in new tab)
The Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) is a scalable and sensitive method for profiling chromatin accessibility, enabling the identification of cis-regulatory elements (CREs) that govern gene expression in diverse cellular contexts. Although ATAC-seq is routinely applied to both bulk and single-cell samples, we reveal that its peak calling process is compromised by local biases in DNA dosage, arising not only from copy number variations (CNVs) but also from...
Read the original article